Abstract
Artificial intelligence and machine learning are powerful tools in analyzing electronic health records (EHRs) for healthcare research. Despite the recognized importance of family health history, in healthcare research individual patients are often treated as independent samples, overlooking family relations. To address this gap, we present ALIGATEHR, which models predicted family relations in a graph attention network and integrates this information with a medical ontology representation. Taking disease risk prediction as a use case, we demonstrate that explicitly modeling family relations significantly improves predictions across the disease spectrum. We then show how ALIGATEHR’s attention mechanism, which links patients’ disease risk to their relatives’ clinical profiles, successfully captures genetic aspects of diseases using only EHR diagnosis data. Finally, we use ALIGATHER to successfully distinguish the two main inflammatory bowel disease subtypes (Crohn’s disease and ulcerative colitis), illustrating its great potential for improving patient representation learning for predictive and descriptive modeling of EHRs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Yale-BI Biomedical Data Science Fellowship
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* e-mail: zuoheng.wang{at}yale.edu; johann.de_jong{at}boehringer-ingelheim.com
Full list of Boehringer Ingelheim – Global Computational Biology and Digital Sciences authors listed in Supplementary Information
Data Availability
The data that support the findings of this study are available from IBM Watson Health, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available.
